To evaluate the clinical utility of AFI and magnification NBI to detect high-grade dysplasia (HGD) and early esophageal adenocarcinoma (EAC) and the interobserver agreement.
Prospective tandem study of eligible patients.
Single, academic tertiary care center.
Forty-two patients with a history of confirmed BE were prospectively enrolled.
The BE segment was examined under high-definition white-light endoscopy, and the presence of visible lesions was recorded. Subsequently, AFI and magnification NBI were performed in tandem on areas of the BE segment away from visible lesions; images obtained by these 2 systems were graded according to the color of reflected light and surface patterns, respectively. Biopsy specimens were obtained at the end of the procedure.
The sensitivity, specificity, positive predictive value, and negative predictive value (NPV) of the AFI and NBI patterns for the detection of HGD/EAC and interobserver agreement.
Of the 42 patients enrolled, 14 (33 % ) had HGD/EAC. On patient-based analysis, AFI alone had a sensitivity, specificity, and NPV of 50 % , 61 % , and 71 % , respectively, and the overall accuracy for the detection of HGD/EAC patients was 57 % . By using magnification NBI in tandem fashion, the sensitivity and NPV improved to 71 % and 76 % , respectively, with a decrease in specificity to 46 % and in overall accuracy to 55 % . The 2 techniques had moderate interobserver agreement for both the patterns and prediction of histology.
Uncontrolled study performed at an academic center by expert endoscopists in a high-risk population.
By using a multimodality endoscope, both AFI and magnification NBI had limited clinical accuracy and moderate overall interobserver agreement. AFI does not appear to be useful as a broad-based technique for the detection of neoplasia in patients with BE.